Daily Archives: March 28, 2017

The US Multi-Society Task Force on Colorectal Cancer, with invited experts, developed a consensus statement and recommendations to assist health care providers with appropriate management of patients with biallelic mismatch repair deficiency (BMMRD)… Continue reading →

There is growing interest in the use of bone marrow cells to treat liver fibrosis, however little is known about their anti-fibrotic efficacy or the identity of their effector cell(s). Sphingosine-1-phosphate (S1P) mediates egress of immune cells from … Continue reading →

Patients with acute liver failure (ALF) have defects in innate immune responses to microbes (immuneparesis) and are susceptible to sepsis. Cytotoxic T-lymphocyte associated protein 4 (CTLA4), which interacts with the membrane receptor B7 (also called C… Continue reading →

The global burden of disease attributable to viral hepatitis is increasing. In 2013, viral hepatitis was the seventh leading cause of death worldwide, owing to cirrhosis and hepatocellular carcinoma (HCC).1 HCC is the fastest increasing cause of cancer… Continue reading →

This may be the first time that the incoming president of the AGA has been introduced by a colleague who is also their spouse. I have known Sheila as her lab partner in college, husband, collaborator and still, her lab partner. We have car-pooled to wo… Continue reading →

Dietary exposure to aflatoxin is an important risk factor for hepatocellular carcinoma (HCC). However, little is known about the genomic features and mutations of aflatoxin-associated HCCs compared with HCCs not associated with aflatoxin exposure. We i… Continue reading →

“Where there is no vision, the people disappear”—King Solomon Proverbs Continue reading →